We often only seek medical attention when we feel that something is wrong. This can sometimes be too late as symptoms may not appear until the condition is advanced. Today, we have the technology to detect issues early, before pain, discomfort, or weakness is felt.
Early detection can help you save money over time, decrease hospitalization time, and preserve your overall health. Outcomes are also much better when it comes to managing early-stage disease than treating a problem in later stages. Early diagnosis and treatment also provides a better quality of life in the long run.
Each year, over 1 million people worldwide are diagnosed with gastric (stomach) cancer and over 800,000 people die of the disease. It is among the top 5 deadliest cancers worldwide for both men and women.
The good news is that gastric cancer is curable if detected early. Close to 90% of patients diagnosed with stage -1 gastric cancer have good outcomes with curative treatment. However, the survival rate drops to less than 20% for a patient diagnosed with stage -4 gastric cancer.
Gastric cancer typically causes no symptoms in the early stages of the disease. Knowing your risk of gastric cancer and managing that risk by taking action to get screened regularly before you experience any symptoms is the key to early detection. In countries without gastric cancer screening, more than 60% of gastric cancer patients are diagnosed in the later stages when treatment is less effective and more costly.
GASTROClear is a cancer blood test – the first of its kind in the world – designed to detect gastric cancer in people who may not yet be experiencing any symptoms.
Gastric cancer is typically diagnosed through gastroscopy, also known as upper gastrointestinal endoscopy, with biopsy. However, this method is costly and invasive, sometimes requiring anesthesia. During this procedure, a doctor uses a tube with a light and camera on it to look for any physical changes on the surface of the upper digestive tract.
Compared to gastroscopy, GASTROClear is a minimally invasive and less time-consuming method of screening for gastric cancer. This cancer marker test measures the levels of microRNA in the blood, specifically picking up 12 microRNAs that are associated with gastric cancer. Diseases often have abnormal expression of certain microRNAs, so when a disease occurs, we can detect changes in the levels of these microRNAs.
Testing with GASTROClear allows doctors to assess the risk of gastric cancer, and help patients manage that risk and take action early for the best possible outcome.
Regular screening can increase the chances of detecting gastric cancer in the early stages. Find out how you can prevent and detect gastric cancer early.
Gastric cancer usually shows no signs or symptoms in the early stages. Knowing and proactively managing your risk through regular screening is the key to early detection.
Early diagnosis coupled with timely life-saving treatment can lead to good outcomes for patients with gastric cancer.
Gastric cancer is a disease in which malignant, or cancerous, cells form in the lining of the stomach.
The first signs of gastric cancer are often vague. Specifically, the signs may be heartburn, indigestion, a change in appetite, nausea, and vomiting.
Men are at higher risk of gastric cancer than women. However, the signs and symptoms of gastric cancer are similar for men and women.
Gastric cancer typically causes no symptoms in the early stages of the disease. As the disease advances, the symptoms are often vague and non-specific.
There is no sure way to prevent gastric cancer, but there are things you can do to lower your risk. These include staying at a healthy weight, maintaining a lifestyle with regular physical activity, avoiding or limiting alcohol, and keeping to a healthy diet.
Stomach cancer is curable if detected in the early stages.
Gastroscopy, also known as upper gastrointestinal endoscopy or oesophago-gastro-duodenoscopy (OGD), is a procedure where a tube with a light and camera on it is used to look for any physical changes on the surface of the upper digestive tract.
You are required to fast for at least 6 hours before the procedure to ensure that your stomach is completely empty.
No special preparation is needed for the GASTROClear test, which only requires a simple blood draw.
No. Other tests can suggest that cancer is present, but a confirmed diagnosis is only possible with a biopsy.
Hereditary diffuse gastric cancer (HDGC) is a rare inherited condition associated with an increased risk of gastric cancer. The gene most commonly associated with HDGC is called CDH1. A mutation (alteration) in the CDH1 gene gives a person an increased risk of developing gastric cancer.